Suppr超能文献

毒性弥漫性甲状腺肿周期性瘫痪——来自印度南部的回顾性研究。

Thyrotoxic periodic paralysis - a retrospective study from Southern India.

机构信息

Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India.

Department of Critical Care, Christian Medical College, Vellore, India.

出版信息

Eur Thyroid J. 2024 Nov 11;13(6). doi: 10.1530/ETJ-24-0164. Print 2024 Dec 1.

Abstract

OBJECTIVE

Thyrotoxic periodic paralysis is a rare manifestation of thyrotoxicosis. Here, we describe the clinical and biochemical features and treatment outcomes of this disorder.

METHODS

This retrospective study was conducted at a tertiary care centre in southern India. The clinical and biochemical features, treatment received, and therapeutic outcomes of all patients with thyrotoxicosis and acute flaccid paralysis without any other identifiable causes (cases for the study) were compared with an equal number of consecutively selected patients who presented with thyrotoxicosis but without features of paralysis (controls for the study) during the same period.

RESULTS

In total, 41 cases and controls were included in this study. The proportion of males was 92.6% and 43.9% in the cases and controls, respectively. The mean age was 32.8 (±7.6) years (cases) and 39.7 (±11.3) years (controls). In the cases, 20% of patients presented without clinical thyrotoxic features. Graves' disease was the most common aetiology of thyrotoxicosis in both groups (92.6% of cases and 87.8% of controls). The prevalence of goitre was significantly higher among controls (90.2%) than among cases (53.7%). The mean serum potassium, free T4, total T4 and total T3 levels were significantly lower in the cases than in the controls. In these cases, two patients had an additional aetiology for persistent hypokalaemia, likely Gitelman's syndrome.

CONCLUSION

This is one of the largest series of thyrotoxic periodic paralysis cases in India. In subjects with thyrotoxicosis, serum potassium, free T4, total T4 and total T3 levels were significantly lower in those with periodic paralysis than in those without.

摘要

目的

甲状腺毒症周期性瘫痪是甲状腺毒症的一种罕见表现。在此,我们描述了这种疾病的临床和生化特征以及治疗结果。

方法

本回顾性研究在印度南部的一家三级保健中心进行。将所有甲状腺毒症伴急性弛缓性瘫痪且无其他可识别病因的患者(研究病例)的临床和生化特征、所接受的治疗以及治疗结果与同期因甲状腺毒症但无瘫痪特征的相同数量连续选择的患者(研究对照)进行比较。

结果

本研究共纳入 41 例病例和对照。男性比例分别为病例组的 92.6%和对照组的 43.9%。平均年龄分别为病例组的 32.8(±7.6)岁和对照组的 39.7(±11.3)岁。在病例组中,20%的患者无临床甲状腺毒症表现。两组中 Graves 病均为甲状腺毒症的最常见病因(病例组为 92.6%,对照组为 87.8%)。对照组的甲状腺肿患病率明显高于病例组(90.2% vs. 53.7%)。病例组的血清钾、游离 T4、总 T4 和总 T3 水平均明显低于对照组。在这些病例中,有 2 例患者存在持续性低钾血症的其他病因,可能为 Gitelman 综合征。

结论

这是印度最大的甲状腺毒症周期性瘫痪病例系列之一。在甲状腺毒症患者中,周期性瘫痪患者的血清钾、游离 T4、总 T4 和总 T3 水平明显低于无周期性瘫痪患者。

相似文献

5
Analytic review: thyrotoxic periodic paralysis: a review.分析性综述:甲状腺毒症性周期性瘫痪:综述。
J Intensive Care Med. 2010 Mar-Apr;25(2):71-7. doi: 10.1177/0885066609358849. Epub 2010 Jan 19.
7
[Not Available].[无可用内容]。
Tidsskr Nor Laegeforen. 2024 Apr 30;144(9). doi: 10.4045/tidsskr.23.0736. Print 2024 Aug 20.

本文引用的文献

8
Global epidemiology of hyperthyroidism and hypothyroidism.全球甲状腺功能亢进症和甲状腺功能减退症的流行病学。
Nat Rev Endocrinol. 2018 May;14(5):301-316. doi: 10.1038/nrendo.2018.18. Epub 2018 Mar 23.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验